DURHAM, NC – September 14, 2020

Bio Products Laboratory (BPL) USA, a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, has been named one of the Best Places to Work by Triangle Business Journal. This award acknowledges BPL USA’s achievements in creating an environment that demonstrates exceptional teamwork, leadership, and employee engagement.

BPL USA was selected among 50 companies for the award based on employee survey results that examined communication and resources, manager effectiveness, personal engagement, individual needs, team dynamics, and trust in leadership. Eligible companies were required to have at least 10 employees in the 16 counties that make up the Triangle region.

“It’s an honor to be recognized as one of the Triangle’s best places to work, especially amid new challenges to the workplace in 2020,” said Bob Rossilli, US President and Chief Commercial Officer, Global Business at BPL. “We’re proud of the unique culture we’ve built here from the ground up. We put our people first, treat each other with respect and emphasize a commitment to working hard or hustling on behalf of the patients who rely on our products.”

This award is an extension of BPL’s increasingly positive impact in the rare diseases space and the Triangle business community. During the past five years, BPL USA has grown an impressive 800% fueled by an unrelenting commitment to serving the patients who rely on plasma-based products. By building a culture of hustle, integrity and teamwork, BPL USA has reliably met the needs of patients and distributers to provide access to high quality medicines. As the U.S. continues to undergo a national health crisis, BPL USA is looking to the future to provide reliable and innovative patient care.

About Bio Products Laboratory USA (BPL USA)

BPL USA, headquartered in Durham, NC, focuses on providing access to BPL’s plasma-derived therapies to the US market. BPL USA is dedicated to delivering transformative therapies to patients in the areas of Immunology, rare bleeding disorders, and critical care. In addition to five currently available specialty medicines in the US market, BPL is also investing in the development of a robust pipeline of future product candidates for patients with rare and orphan diseases. Since receiving its first US FDA approval in 2009, BPL has proudly built a strong culture and reputation as an industry leader with specialty pharmacies, healthcare professionals, and patient advocacy organizations. BPL USA is part of a global company, Bio Products Laboratory, which boasts a vibrant 60-year heritage in plasma research, technology, and manufacturing. For more information about BPL in the United States, please visit www.bpl-us.com.

About Bio Products Laboratory (BPL)

Recognising the power of plasma and with over 60 years heritage in the industry, BPL supplies high-quality plasma derived medicines to meet the needs of clinicians, patients and customers globally. Headquartered in the United Kingdom and with plasma collection centres across the United States, we are dedicated to producing medicines for the treatment of immune deficiencies, bleeding disorders and infectious diseases as well for critical care. BPL invests in the latest R&D, technology and manufacturing methods, and continuously adapts to ensure that we continue to serve all our stakeholders effectively. For more information visit http://www.bplgroup.com

BPL consists of two operating divisions - BPL Plasma and BPL Therapeutics. BPL Plasma, headquartered in Austin, Texas and operating in the USA, collects plasma from donors, in around 51 centres across the US. BPL Plasma employs over 2000 staff, to support the needs of donors and to ensure high-quality plasma collection in all their centres. Plasma collection is regulated by both FDA and MHRA, and BPL Plasma follow industry guidelines. BPL Plasma operates clean and safe plasma facilities, staffed with trained personnel, dedicated to supporting donors through the process that leads to the donation of plasma. Plasma is shipped to the headquarters of BPL Therapeutics in Elstree, United Kingdom. The plasma is fractionated, purified, and filled through the efforts of our over 1000 employees involved in production, quality, R&D, commercial, customer services and administrative activities. BPL’s plasma derived medicines are commercially available in the UK, USA and 30 plus other countries around the world through our network of local distribution partners.


Melissa Mowery, APCO Worldwide
(703) 407-2157